HCG Q2 FY26 results: revenue up, profit declines YoY

Results restatedExceptional itemResults View source PDF Explain this filing

HCG · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.4%Reaction day

₹749.95

prior close

₹740.00

announcement price

After-mkt

timing

Nifty Microcap 250market · index membership as recorded later (tracked since Jun 2026)-0.1%-0.3% vs market

Hospital peers, median of 18sector-0.5%+0.1% vs sector

On the reaction day the stock moved 0.3 pts less than Nifty Microcap 250 and 0.1 pts more than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.4

10m

+0.2

15m

-0.0

30m

-1.1

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-0.4-0.1-0.3-0.5+0.1

Next day

-1.9-0.2-1.7-0.6-1.3

-1.8+0.4-2.3+0.5-2.3

-2.0-0.4-1.6-1.0-1.0

-0.2-0.6+0.4-1.8+1.6

-0.9-0.9-0.0-1.1+0.2

-5.0-3.0-2.0-1.5-3.5

15d

-4.7-3.9-0.8-3.0-1.7

-4.0-4.8+0.8-2.5-1.6

-10.7-7.8-2.9-7.0-3.7

-22.4-7.2-15.2-8.6-13.8

UpDownMarket · Nifty Microcap 250Sector · Hospital peers, median of 18Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

HCG posted Q2 and H1 FY26 results on Nov 12. Consolidated Q2 revenue grew to Rs 645.16 cr (Rs 552.47 cr YoY), PAT at Rs 20.66 cr (Rs 21.02 cr). H1 FY26 revenue rose to Rs 1,256.96 cr from Rs 1,079.16 cr, PAT dipped to Rs 26.89 cr from Rs 31.88 cr. Standalone Q2 PAT fell to Rs 10.78 cr from Rs 17.95 cr. Board allotted 7,537 shares via ESOP and approved Rs 7 cr investment in Kenya unit. Prior period numbers restated for business transfer. Exceptional charges of Rs 19.84 cr in H1 FY26.

Likely market impact

Revenue grew but profits declined meaningfully YoY. Watch impact of KKR-backed promoter change and H1 exceptional charges on outlook.